News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
FDA Meets on Merck & Co., Inc.'s Mevacor; OTC Cholesterol Drug Sought
December 13, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Drug maker Merck will make a third attempt Thursday to convince the government to allow its cholesterol-lowering pill Mevacor to be sold without a prescription.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
MORE ON THIS TOPIC
Drug pricing
FDA Advances Drug Importation Plan as Canada Moves To Protect Its Supply
May 22, 2025
·
2 min read
·
Annalee Armstrong
Adcomms
Pfizer’s Talzenna Expansion Fails To Earn FDA Advisory Committee’s Support
May 22, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
‘We Don’t Believe This Is Right’: Lilly Bristles as CMS Leaves Obesity Drugs Out of Medicare
May 22, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Moderna Shares Fall as Combo Flu/COVID-19 Vaccine Application Pulled
May 21, 2025
·
2 min read
·
Dan Samorodnitsky
